BioSpace News Archive

Business

Kurt Hammond Named Exo® Chief Commercial Officer to Drive the Future of Medical Imaging

Exo, a pioneering medical imaging software and devices company, announced the appointment of Kurt Hammond to Chief Commercial Officer.

August 24, 2023
·
3 min read
Lone Star Bio

Biogenysis’ International Patent Application, Covering Its Anti-SARS-CoV-2 Monoclonal Antibodies, Advances to Prosecution in Europe and as a U.S. National Stage Application.

Biogenysis, Inc. (OTC PINK:ENZC) (or the “Company”). Biogenysis, a subsidiary of Enzolytics, Inc., announces the progress of its Patent Cooperation Treaty (PCT) application covering its inventions relating to Anti-SARS-CoV-2 Monoclonal Antibodies.

August 24, 2023
·
11 min read
Pharm Country

MiNK Therapeutics to Participate in September 2023 Investor Conferences

MiNK Therapeutics announced that Dr. Jennifer Buell, Chief Executive Officer and President, will participate in the following upcoming investor conferences.

August 24, 2023
·
1 min read
Genetown

Bayer: How Innovative Farmers Are Tailoring Their Crop Protection

When it comes to raising crops, protecting them through harvest is often the toughest part of the job.

August 24, 2023
·
5 min read
Pharm Country

Verrica Pharmaceuticals Announces First Sale of YCANTH™ to FFF Enterprises

Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the first commercial sale of YCANTH™ to its exclusive distributor, FFF Enterprises Inc. (“FFF”).

August 24, 2023
·
8 min read
Business

Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS)

Simulations Plus, Inc. is proud to announce that Dr. Viera Lukacova, Chief Science Officer of the SLP Division, has been elevated to the status of Fellow within the American Association of Pharmaceutical Scientists and will be formally inducted at the annual PharmSci 360 meeting on October 22, 2023.

August 24, 2023
·
3 min read
BioMidwest

Aptar Announces 2023 Investor Day

AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, will host an Investor Day on Friday, September 8, 2023.

August 24, 2023
·
1 min read
Drug Development

Preclinical Study Builds on Growing Body of Evidence Showcasing Exogenous Nicotinamide Mononucleotide (NMN) Must be Converted to Nicotinamide Riboside (NR), Making NR a More Efficient Nicotinamide Adenine Dinucleotide (NAD+) Precursor to NMN

ChromaDex Corp. as reported in the peer-reviewed journal International Journal of Molecular Sciences by a team of scientists led by Dr. Yue Yang, Assistant Professor of Research in Pharmacology at Weill Cornell Medicine in New York.

August 24, 2023
·
7 min read
New Company Launches to offer Development of Point-of-Care Rapid Immunodiagnostic Lateral Flow Tests.

Gold Colloid, Co., a new company focused on the development of point-of-care rapid immunodiagnostic lateral flow tests, today announced its launch

August 24, 2023
·
1 min read
Business

CARGO Therapeutics Appoints Biotech Life Sciences Leaders to Board of Directors

CARGO Therapeutics, Inc. (CARGO) today announced the addition of independent directors to the Board of Directors following its recent $200 million Series A financing in March 2023.

August 24, 2023
·
4 min read